The Addition of Cixutumumab or Temozolomide to Intensive Multiagent Chemotherapy Is Feasible but Does Not Improve Outcome for Patients with Metastatic Rhabdomyosarcoma: A Report from the Children’s Oncology Group

PURPOSE: Outcome for patients with metastatic rhabdomyosarcoma (RMS) remains poor. A previous COG study (ARST0431) for patients with metastatic RMS showed no improvement in outcome using multiple cytotoxic agents in a dose intensive manner. We report the results of the subsequent COG study (ARST08P1...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer
Hlavní autoři: Malempati, Suman, Weigel, Brenda J., Chi, Yueh-Yun, Tian, Jing, Anderson, James R., Parham, David M., Teot, Lisa A., Rodeberg, David A., Yock, Torunn I., Shulkin, Barry L., Spunt, Sheri L., Meyer, William H., Hawkins, Douglas S.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6329653/
https://ncbi.nlm.nih.gov/pubmed/30351457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.31770
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky